Company profile
SOHM, Inc.
OTC: SHMN · Healthcare · Medical - Pharmaceuticals
#861 of 1,422 Healthcare companies by revenue69th-percentile growth
EA Score
61CFH 61DQ —GM 68SS 43
v0.1 · 45/100 weight · provisional
↑ 3-yr revenue growth, return on assets · ↓ workforce scale, market scale
Methodology →Revenue TTM
$914.5k
Rev growth YoY (TTM)
-17.7%
Net income (FY)
-$506.5k
Employees
11
as of 2026-08-25
Market cap
$1.4M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2M$1.2M2025
Net income-$506.5k-$506.5k2025
Operating income-$505.0k-$505.0k2025
Total assets$7.1M$7.1M2025
Liabilities$3.2M$3.2M2025
Equity$3.9M$3.9M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is SOHM, Inc.’s revenue?
SOHM, Inc. booked $1.2M in FY2025 revenue, growing 24% year over year — faster than most Healthcare companies we track, at a -43.0% net margin.
Peers · Healthcare
SeaStar Medical Holding Corporation30DNRx Pharmaceuticals, Inc.24DLongeveron Inc.30DPeoplesway.com Inc.——Ampio Pharmaceuticals, Inc.——PetVivo Holdings, Inc.38DNeighbors
Riverside →Key facts
CEOBaron Night
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersCorona, CA
ExchangeOTC: SHMN
Employees11
IPO date2010-03-31
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.